{"schema":"hottub-news/story/v1","story":"st_jicnankynwl46ghy6ulq","title":"EADV 2026: Galderma's New Data Show Sustained Improvements with Nemluvio (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitis","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/eadv-2026-galdermas-new-data-show-sustained-improvements-with-nemluvio-jicnankynw","count":1,"items":[{"id":"n_jicnankynwl46ghy6ulq","seq":828787,"kind":"article","title":"EADV 2026: Galderma's New Data Show Sustained Improvements with Nemluvio (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitis","url":"https://www.finanznachrichten.de/nachrichten-2026-09/69711730-eadv-2026-galderma-s-new-data-show-sustained-improvements-with-nemluvio-nemolizumab-for-up-to-three-years-in-patients-with-moderate-to-severe-atopi-004.htm","published":"2026-09-30T05:22:42Z","seen":"2026-09-30T05:22:42Z","lang":"en","country":"DE","source":{"id":"finanznachrichten.de","name":"finanznachrichten.de","domain":"finanznachrichten.de","outlet":{"wikidata":"Q1408247","name":"Finanznachrichten.de","type":"website","designations":["website"]}},"via":"gdelt-gkg-english","topics":["economy","health","politics","education"],"authors":["Business Wire"],"entities":[{"id":"Q581008","name":"Galderma","type":"org"},{"id":"Q30314619","name":"nemolizumab","type":"other"},{"id":"Q268667","name":"atopic dermatitis","type":"other"}],"story":"st_jicnankynwl46ghy6ulq","category":"health","category_p":0.6100000143051147,"sentiment":"positive","tone":0.10000000149011612,"political":0.019999999552965164}]}